Home » Thought Leadership » Podcasts » Speaking of Access: The Manage…

Speaking of Access: The Management of Tumor-Agnostic Therapies

May 20, 2020


Written by: Andrew Gould

Andrew Gould asks our US payer panel for their expert perspectives surrounding the management of tumor-agnostic therapies.

Focusing on KEYTRUDA, VITRAKVI, and ROZLYTREK, the panel discuss how they are managing these therapies as more of them launch in the future.


Apple Podcasts